Streetbeat News

Products Services

QUIK

QuickLogic Corporation has signed a significant seven-figure contract to provide its embedded FPGA (eFPGA) Intellectual Property (IP) for GlobalFoundries' 12LP process. This deal underscores QuickLogic's expertise and the demand for its eFPGA solutions, potentially boosting its financial performance and market position.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:12 pm

NATL

NCR Atleos Corporation (NYSE:NATL), a leader in financial access expansion, announced its partnership with VyStar Credit Union to provide its members with surcharge-free access to cash through the Allpoint ATM Network. This collaboration aims to support VyStar's growth by offering access to over 40,000 ATMs nationwide and more than 10,000 international locations, enhancing the credit union's service offerings to its expanding member base.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:11 pm

SPRO

Spero Therapeutics has received clearance for its Investigational New Drug (IND) application for SPR206, aimed at treating multi-drug resistant (MDR) Gram-negative bacterial infections. This development marks a significant step forward in the company's efforts to address a critical need in the healthcare sector for new antibiotics capable of combating resistant bacteria.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:08 pm

GEHC

GE HealthCare (NASDAQ:GEHC) launched its new LOGIQ ultrasound portfolio, including LOGIQ Totus, at the European Congress of Radiology 2024. The portfolio features advanced AI tools and the LOGIQ AppAPI for third-party applications, aiming to address the global shortage of radiologists and improve clinical efficiency. The LOGIQ E10 Series and LOGIQ Fortis offer AI-based workflow tools, while the LOGIQ Totus provides a versatile solution for full-body imaging. PIUR IMAGING's 'PIUR tUS inside' is integrated for thyroid examination.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:07 pm

KORE

KORE and Medical Guardian have announced a collaboration to launch the first eSIM-powered medical alert device, the MGMini, aimed at enhancing healthcare equity through uninterrupted 24/7 emergency response coverage. This device, leveraging KORE's OmniSIM technology, allows for electronic switching of service carriers to ensure optimal connectivity, addressing cell signal challenges and healthcare access disparities. The MGMini is designed to support 'active aging' by providing seniors with vital resources and instant access to emergency operators and caregivers, benefiting Medical Guardian's membership of over 100,000 individuals.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:06 pm

APLT

Applied Therapeutics announced that the FDA has accepted and granted priority review to its New Drug Application for Govorestat, aimed at treating Classic Galactosemia. This marks a significant milestone for the company as it moves closer to potentially bringing a new treatment option to patients with this rare metabolic disorder.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:06 pm

OESX

Orion Energy Systems announced that its Voltrek EV charging business will be installing 43 EV chargers, marking a significant project for the company.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:05 pm

FOUR

Shift4 (NYSE:FOUR) has been chosen as the official point-of-sale systems partner for the New York Yankees, providing its integrated payments technology for concessions and retail transactions at Yankee Stadium and George M. Steinbrenner Field. This partnership aims to enhance the transaction experience for guests with Shift4's end-to-end commerce solution, which includes hardware, software, and third-party integrations tailored for high-volume venues.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:05 pm

SNN

Smith+Nephew (NYSE:SNN) has entered into a Master Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR). This is the first master agreement of its kind between USAISR and a leading medical technology company, covering all of Smith+Nephew's business units. The agreement aims to facilitate collaborative research efforts, streamline the research agreement process, and leverage both parties' infrastructure and expertise to support innovation in combat casualty care.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:03 pm

CRNX

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) announced an oversubscribed private placement of 8,333,334 shares at $42/share, expecting to raise $350M. The funds are intended for R&D, working capital, and general corporate purposes. The placement, supported by notable institutional investors and managed by several prominent placement agents, is set to close by March 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:02 pm